February 11, 2008
Keiji Nakamura, Ph. D. Pharma Forum Institute, Kamakura Japan http://www.pharma-fi.com/index.html In the past few years, major pharmaceutical companies have been suffering from various adverse effects of blockbusters on the market and candidates under clinical trials such as Pfizer's torcetrapib, GSK's...read more